IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 31 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,943,000 | +1.7% | 2,500,000 | 0.0% | 0.02% | +5.9% |
| Q4 2017 | $2,894,000 | -2.6% | 2,500,000 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $2,970,000 | -11.2% | 2,500,000 | 0.0% | 0.02% | -15.0% |
| Q2 2017 | $3,345,000 | +7.6% | 2,500,000 | 0.0% | 0.02% | +11.1% |
| Q1 2017 | $3,108,000 | +8.6% | 2,500,000 | 0.0% | 0.02% | +5.9% |
| Q4 2016 | $2,861,000 | +20.0% | 2,500,000 | +25.0% | 0.02% | +21.4% |
| Q3 2016 | $2,384,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,000,000 | $1,164,000 | 0.58% |
| CSS LLC/IL | 7,044,000 | $8,236,000 | 0.46% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,392,000 | $39,039,000 | 0.45% |
| DeepCurrents Investment Group LLC | 5,056,000 | $5,872,000 | 0.26% |
| SSI INVESTMENT MANAGEMENT LLC | 3,175,000 | $3,696,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,000,000 | $5,850,000 | 0.17% |
| LINDEN ADVISORS LP | 10,269,000 | $12,015,000 | 0.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,817,000 | $2,126,000 | 0.11% |
| HBK INVESTMENTS L P | 10,116,000 | $11,822,000 | 0.11% |
| LAZARD ASSET MANAGEMENT LLC | 16,000,000 | $18,783,000 | 0.03% |